{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:34:06Z","timestamp":1793198046730,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T00:00:00Z","timestamp":1627344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cancer stem cells (CSCs) represent a population of cells within the tumor able to drive tumorigenesis and known to be highly resistant to conventional chemotherapy and radiotherapy. In this work, we show a new role for ETV7, a transcriptional repressor member of the ETS family, in promoting breast cancer stem-like cells plasticity and resistance to chemo- and radiotherapy in breast cancer (BC) cells. We observed that MCF7 and T47D BC-derived cells stably over-expressing ETV7 showed reduced sensitivity to the chemotherapeutic drug 5-fluorouracil and to radiotherapy, accompanied by an adaptive proliferative behavior observed in different culture conditions. We further noticed that alteration of ETV7 expression could significantly affect the population of breast CSCs, measured by CD44\n                    <jats:sup>+<\/jats:sup>\n                    \/CD24\n                    <jats:sup>low<\/jats:sup>\n                    cell population and mammosphere formation efficiency. By transcriptome profiling, we identified a signature of Interferon-responsive genes significantly repressed in cells over-expressing ETV7, which could be responsible for the increase in the breast CSCs population, as this could be partially reverted by the treatment with IFN-\u03b2. Lastly, we show that the expression of the IFN-responsive genes repressed by ETV7 could have prognostic value in breast cancer, as low expression of these genes was associated with a worse prognosis. Therefore, we propose a novel role for ETV7 in breast cancer stem cells\u2019 plasticity and associated resistance to conventional chemotherapy and radiotherapy, which involves the repression of a group of IFN-responsive genes, potentially reversible upon IFN-\u03b2 treatment. We, therefore, suggest that an in-depth investigation of this mechanism could lead to novel breast CSCs targeted therapies and to the improvement of combinatorial regimens, possibly involving the therapeutic use of IFN-\u03b2, with the aim of avoiding resistance development and relapse in breast cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41419-021-04005-y","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T05:03:12Z","timestamp":1627362192000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes"],"prefix":"10.1038","volume":"12","author":[{"given":"Laura","family":"Pezz\u00e8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erna Marija","family":"Me\u0161kyt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7383-6576","authenticated-orcid":false,"given":"Mattia","family":"Forcato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7359-4282","authenticated-orcid":false,"given":"Stefano","family":"Pontalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalina Aleksandra","family":"Badowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Rizzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira-Ida","family":"Skvortsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-7078","authenticated-orcid":false,"given":"Silvio","family":"Bicciato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9231-379X","authenticated-orcid":false,"given":"Yari","family":"Ciribilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,27]]},"reference":[{"key":"4005_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA: Cancer J Clin"},{"key":"4005_CR2","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1038\/onc.2014.475","volume":"34","author":"A Skibinski","year":"2015","unstructured":"Skibinski A, Kuperwasser C. The origin of breast tumor heterogeneity. Oncogene. 2015;34:5309\u201316.","journal-title":"Oncogene"},{"key":"4005_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.ctrv.2014.07.005","volume":"40","author":"A Sonnenblick","year":"2014","unstructured":"Sonnenblick A, Fumagalli D, Sotiriou C, Piccart M. Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up? Cancer Treat. Rev. 2014;40:1089\u201395.","journal-title":"Cancer Treat. Rev."},{"key":"4005_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 2011;22:1736\u201347.","journal-title":"Ann. Oncol."},{"key":"4005_CR5","doi-asserted-by":"publisher","first-page":"R337","DOI":"10.1530\/ERC-16-0121","volume":"23","author":"CG Murphy","year":"2016","unstructured":"Murphy CG, Dickler MN. Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies. Endocr Relat Cancer. 2016;23:R337\u2013352.","journal-title":"Endocr Relat Cancer"},{"key":"4005_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150:165\u201378.","journal-title":"Cell"},{"key":"4005_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2789","volume":"10","author":"JI Fletcher","year":"2010","unstructured":"Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147\u201356.","journal-title":"Nat Rev Cancer"},{"key":"4005_CR8","doi-asserted-by":"publisher","first-page":"59950","DOI":"10.18632\/oncotarget.19048","volume":"8","author":"HC Zheng","year":"2017","unstructured":"Zheng HC. The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017;8:59950\u201364.","journal-title":"Oncotarget"},{"key":"4005_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2015.01.001","volume":"42","author":"JA Ajani","year":"2015","unstructured":"Ajani JA, Song S, Hochster HS, Steinberg IB. Cancer stem cells: the promise and the potential. Semin Oncol. 2015;42:S3\u201317.","journal-title":"Semin Oncol."},{"key":"4005_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4252\/wjsc.v7.i1.27","volume":"7","author":"MC Cabrera","year":"2015","unstructured":"Cabrera MC, Hollingsworth RE, Hurt EM. Cancer stem cell plasticity and tumor hierarchy. World J Stem Cells. 2015;7:27\u201336.","journal-title":"World J Stem Cells"},{"key":"4005_CR11","doi-asserted-by":"publisher","first-page":"44191","DOI":"10.18632\/oncotarget.6176","volume":"6","author":"T Wang","year":"2015","unstructured":"Wang T, Shigdar S, Gantier MP, Hou Y, Wang L, Li Y, et al. Cancer stem cell targeted therapy: progress amid controversies. Oncotarget. 2015;6:44191\u2013206.","journal-title":"Oncotarget"},{"key":"4005_CR12","doi-asserted-by":"crossref","unstructured":"Doherty MR, Smigiel JM, Junk DJ, Jackson MW. Cancer stem cell plasticity drives therapeutic resistance. Cancers (Basel) 2016;8:8.","DOI":"10.3390\/cancers8010008"},{"key":"4005_CR13","doi-asserted-by":"publisher","first-page":"12111","DOI":"10.18632\/oncotarget.2545","volume":"5","author":"A Bisio","year":"2014","unstructured":"Bisio A, Zamborszky J, Zaccara S, Lion M, Tebaldi T, Sharma V, et al. Cooperative interactions between p53 and NFkappaB enhance cell plasticity. Oncotarget. 2014;5:12111\u201325.","journal-title":"Oncotarget"},{"key":"4005_CR14","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1038\/sj.onc.1204038","volume":"19","author":"FO Bartel","year":"2000","unstructured":"Bartel FO, Higuchi T, Spyropoulos DD. Mouse models in the study of the Ets family of transcription factors. Oncogene. 2000;19:6443\u201354.","journal-title":"Oncogene"},{"key":"4005_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35099076","volume":"2","author":"AD Sharrocks","year":"2001","unstructured":"Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2:827\u201337.","journal-title":"Nat Rev Mol Cell Biol."},{"key":"4005_CR16","first-page":"F1","volume":"1377","author":"J Dittmer","year":"1998","unstructured":"Dittmer J, Nordheim A. Ets transcription factors and human disease. Biochim Biophys Acta. 1998;1377:F1\u201311.","journal-title":"Biochim Biophys Acta"},{"key":"4005_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/labinvest.2011.186","volume":"92","author":"JR Oliver","year":"2012","unstructured":"Oliver JR, Kushwah R, Hu J. Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease. Lab Investig. 2012;92:320\u201330.","journal-title":"Lab Investig."},{"key":"4005_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10456-016-9511-z","volume":"19","author":"MP Craig","year":"2016","unstructured":"Craig MP, Sumanas S. ETS transcription factors in embryonic vascular development. Angiogenesis. 2016;19:275\u201385.","journal-title":"Angiogenesis"},{"key":"4005_CR19","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1016\/j.ejca.2005.08.013","volume":"41","author":"A Seth","year":"2005","unstructured":"Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005;41:2462\u201378.","journal-title":"Eur J Cancer"},{"key":"4005_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nature06024","volume":"448","author":"SA Tomlins","year":"2007","unstructured":"Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature. 2007;448:595\u20139.","journal-title":"Nature"},{"key":"4005_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3109\/10409238.2013.838202","volume":"48","author":"A Kar","year":"2013","unstructured":"Kar A, Gutierrez-Hartmann A. Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol. Biol. 2013;48:522\u201343.","journal-title":"Crit Rev Biochem Mol. Biol."},{"key":"4005_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrc.2017.20","volume":"17","author":"GM Sizemore","year":"2017","unstructured":"Sizemore GM, Pitarresi JR, Balakrishnan S, Ostrowski MC. The ETS family of oncogenic transcription factors in solid tumours. Nat Rev Cancer. 2017;17:337\u201351.","journal-title":"Nat Rev Cancer"},{"key":"4005_CR23","first-page":"265","volume":"7","author":"AM Quintana","year":"2014","unstructured":"Quintana AM, Picchione F, Klein Geltink RI, Taylor MR, Grosveld GC. Zebrafish ETV7 regulates red blood cell development through the cholesterol synthesis pathway. Dis. Model. Mech. 2014;7:265\u201370.","journal-title":"Dis. Model. Mech"},{"key":"4005_CR24","doi-asserted-by":"crossref","unstructured":"Numata M, Geltink RK, Grosveld G. The ETS transcription factor ETV7 exhausts hematopoietic stem cells by enhancing the cell cycle entry and cell proliferation. Blood 2013;122:733.","DOI":"10.1182\/blood.V122.21.733.733"},{"key":"4005_CR25","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1158\/0008-5472.CAN-04-0839","volume":"64","author":"H Kawagoe","year":"2004","unstructured":"Kawagoe H, Potter M, Ellis J, Grosveld GCTEL2, an ETS. factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation. Cancer Res. 2004;64:6091\u20136100.","journal-title":"Cancer Res"},{"key":"4005_CR26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4049\/jimmunol.1501032","volume":"197","author":"CM Minutti","year":"2016","unstructured":"Minutti CM, Garcia-Fojeda B, Saenz A, de Las Casas-Engel M, Guillamat-Prats R, de Lorenzo A, et al. Surfactant protein A prevents IFN-gamma\/IFN-gamma receptor interaction and attenuates classical activation of human alveolar macrophages. J Immunol. 2016;197:590\u20138.","journal-title":"J Immunol."},{"key":"4005_CR27","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1016\/j.celrep.2016.08.051","volume":"16","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, Kang K, Giannopoulou E, Fang C, Ivashkiv LB. IFN-gamma Induces Histone 3 Lysine 27 trimethylation in a small subset of promoters to Stably silence gene expression in human macrophages. Cell Rep. 2016;16:3121\u20139.","journal-title":"Cell Rep."},{"key":"4005_CR28","doi-asserted-by":"publisher","first-page":"e13429","DOI":"10.1111\/ctr.13429","volume":"32","author":"M Matz","year":"2018","unstructured":"Matz M, Heinrich F, Zhang Q, Lorkowski C, Seelow E, Wu K, et al. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation. Clin Transpl. 2018;32:e13429.","journal-title":"Clin Transpl."},{"key":"4005_CR29","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/MCB.25.6.2395-2405.2005","volume":"25","author":"M Cardone","year":"2005","unstructured":"Cardone M, Kandilci A, Carella C, Nilsson JA, Brennan JA, Sirma S, et al. The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis. Mol. Cell Biol. 2005;25:2395\u2013405.","journal-title":"Mol. Cell Biol."},{"key":"4005_CR30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2005-03-1196","volume":"107","author":"C Carella","year":"2006","unstructured":"Carella C, Potter M, Bonten J, Rehg JE, Neale G, Grosveld GC. The ETS factor TEL2 is a hematopoietic oncoprotein. Blood. 2006;107:1124\u201332.","journal-title":"Blood"},{"key":"4005_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11248-018-0104-z","volume":"28","author":"M Numata","year":"2019","unstructured":"Numata M, Klein Geltink RI, Grosveld GC. Establishment of a transgenic mouse to model ETV7 expressing human tumors. Transgenic Res. 2019;28:115\u201328.","journal-title":"Transgenic Res"},{"key":"4005_CR32","doi-asserted-by":"publisher","first-page":"eaar3938","DOI":"10.1126\/sciadv.aar3938","volume":"4","author":"FC Harwood","year":"2018","unstructured":"Harwood FC, Klein Geltink RI, O\u2019Hara BP, Cardone M, Janke L, Finkelstein D, et al. ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer. Sci. Adv. 2018;4:eaar3938.","journal-title":"Sci. Adv."},{"key":"4005_CR33","doi-asserted-by":"publisher","first-page":"29240","DOI":"10.18632\/oncotarget.5074","volume":"6","author":"Y Sang","year":"2015","unstructured":"Sang Y, Chen MY, Luo D, Zhang RH, Wang L, Li M, et al. TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma. Oncotarget. 2015;6:29240\u201353.","journal-title":"Oncotarget"},{"key":"4005_CR34","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.3892\/or.2014.3014","volume":"31","author":"O Maeda","year":"2014","unstructured":"Maeda O, Ando T, Ohmiya N, Ishiguro K, Watanabe O, Miyahara R, et al. Alteration of gene expression and DNA methylation in drug-resistant gastric cancer. Oncol. Rep. 2014;31:1883\u201390.","journal-title":"Oncol. Rep."},{"key":"4005_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13058-015-0666-0","volume":"18","author":"CL Piggin","year":"2016","unstructured":"Piggin CL, Roden DL, Gallego-Ortega D, Lee HJ, Oakes SR, Ormandy CJ. ELF5 isoform expression is tissue-specific and significantly altered in cancer. Breast Cancer Res. 2016;18:4.","journal-title":"Breast Cancer Res."},{"key":"4005_CR36","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neo.2018.06.008","volume":"20","author":"F Alessandrini","year":"2018","unstructured":"Alessandrini F, Pezze L, Menendez D, Resnick MA, Ciribilli Y. ETV7-mediated DNAJC15 repression leads to doxorubicin resistance in breast cancer cells. Neoplasia. 2018;20:857\u201370.","journal-title":"Neoplasia"},{"key":"4005_CR37","doi-asserted-by":"publisher","first-page":"31569","DOI":"10.18632\/oncotarget.5035","volume":"6","author":"Y Ciribilli","year":"2015","unstructured":"Ciribilli Y, Singh P, Spanel R, Inga A, Borlak J. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas. Oncotarget. 2015;6:31569\u201392.","journal-title":"Oncotarget"},{"key":"4005_CR38","doi-asserted-by":"publisher","first-page":"e69152","DOI":"10.1371\/journal.pone.0069152","volume":"8","author":"I Raimondi","year":"2013","unstructured":"Raimondi I, Ciribilli Y, Monti P, Bisio A, Pollegioni L, Fronza G, et al. P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements. PLoS ONE. 2013;8:e69152.","journal-title":"PLoS ONE"},{"key":"4005_CR39","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.18632\/oncotarget.1845","volume":"5","author":"P Monti","year":"2014","unstructured":"Monti P, Ciribilli Y, Bisio A, Foggetti G, Raimondi I, Campomenosi P, et al. N-P63alpha and TA-P63alpha exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. Oncotarget. 2014;5:2116\u201330.","journal-title":"Oncotarget"},{"key":"4005_CR40","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1093\/nar\/gkt657","volume":"41","author":"Y Ciribilli","year":"2013","unstructured":"Ciribilli Y, Monti P, Bisio A, Nguyen HT, Ethayathulla AS, Ramos A, et al. Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. Nucleic Acids Res. 2013;41:8637\u201353.","journal-title":"Nucleic Acids Res"},{"key":"4005_CR41","doi-asserted-by":"crossref","unstructured":"Lombardo Y, de Giorgio A, Coombes CR, Stebbing J, Castellano L. Mammosphere formation assay from human breast cancer tissues and cell lines. J Vis Exp. 2015;52671.","DOI":"10.3791\/52671"},{"key":"4005_CR42","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet JP, Haeussler M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 2018;46:W242\u2013W245.","journal-title":"Nucleic Acids Res"},{"key":"4005_CR43","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 2014;42:e168.","journal-title":"Nucleic Acids Res"},{"key":"4005_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"4005_CR45","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923\u201330.","journal-title":"Bioinformatics"},{"key":"4005_CR46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"4005_CR47","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284\u20137.","journal-title":"OMICS"},{"key":"4005_CR48","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4005_CR49","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst."},{"key":"4005_CR50","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44:e71.","journal-title":"Nucleic Acids Res"},{"key":"4005_CR51","doi-asserted-by":"publisher","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","volume":"95","author":"LA Doyle","year":"1998","unstructured":"Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad. Sci. USA. 1998;95:15665\u201370.","journal-title":"Proc Natl Acad. Sci. USA"},{"key":"4005_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","volume":"18","author":"RW Robey","year":"2018","unstructured":"Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM. Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer. 2018;18:452\u201364.","journal-title":"Nat Rev Cancer"},{"key":"4005_CR53","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1158\/1541-7786.MCR-17-0353","volume":"16","author":"A Yamada","year":"2018","unstructured":"Yamada A, Nagahashi M, Aoyagi T, Huang WC, Lima S, Hait NC, et al. ABCC1-exported sphingosine-1-phosphate, produced by sphingosine kinase 1, shortens survival of mice and patients with breast cancer. Mol Cancer Res. 2018;16:1059\u201370.","journal-title":"Mol Cancer Res"},{"key":"4005_CR54","doi-asserted-by":"publisher","first-page":"9421","DOI":"10.1074\/jbc.M010070200","volume":"276","author":"X Gu","year":"2001","unstructured":"Gu X, Shin BH, Akbarali Y, Weiss A, Boltax J, Oettgen P, et al. Tel-2 is a novel transcriptional repressor related to the Ets factor Tel\/ETV-6. J Biol Chem. 2001;276:9421\u201336.","journal-title":"J Biol Chem."},{"key":"4005_CR55","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/bcr1982","volume":"10","author":"CM Fillmore","year":"2008","unstructured":"Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008;10:R25.","journal-title":"Breast Cancer Res."},{"key":"4005_CR56","doi-asserted-by":"publisher","first-page":"13792","DOI":"10.1073\/pnas.1713728114","volume":"114","author":"MR Doherty","year":"2017","unstructured":"Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, et al. Interferon-beta represses cancer stem cell properties in triple-negative breast cancer. Proc. Natl Acad. Sci. USA. 2017;114:13792\u20137.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4005_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13058-019-1136-x","volume":"21","author":"MR Doherty","year":"2019","unstructured":"Doherty MR, Parvani JG, Tamagno I, Junk DJ, Bryson BL, Cheon HJ, et al. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer. Breast Cancer Res. 2019;21:54.","journal-title":"Breast Cancer Res."},{"key":"4005_CR58","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277\u201388.","journal-title":"Nat Rev Cancer"},{"key":"4005_CR59","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ijrobp.2004.03.005","volume":"59","author":"TM Pawlik","year":"2004","unstructured":"Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol. 2004;59:928\u201342.","journal-title":"Int J Radiat Oncol."},{"key":"4005_CR60","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000086183","volume":"14","author":"YA Luqmani","year":"2005","unstructured":"Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract. 2005;14:35\u201348.","journal-title":"Med Princ Pract."},{"key":"4005_CR61","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1083\/jcb.139.3.575","volume":"139","author":"MA Schwartz","year":"1997","unstructured":"Schwartz MA. Integrins, oncogenes, and anchorage independence. J Cell Biol. 1997;139:575\u20138.","journal-title":"J Cell Biol."},{"key":"4005_CR62","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.biocel.2012.08.022","volume":"44","author":"ZR Yu","year":"2012","unstructured":"Yu ZR, Pestell TG, Lisanti MP, Pestell RG. Cancer stem cells. Int J Biochem Cell Biol. 2012;44:2144\u201351.","journal-title":"Int J Biochem Cell Biol"},{"key":"4005_CR63","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.stem.2007.10.015","volume":"1","author":"D Balicki","year":"2007","unstructured":"Balicki D. Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1. Cell Stem Cell. 2007;1:485\u20137.","journal-title":"Cell Stem Cell"},{"key":"4005_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2014;2:78\u201391.","journal-title":"Stem Cell Rep."},{"key":"4005_CR65","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133:704\u201315.","journal-title":"Cell"},{"key":"4005_CR66","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.1158\/0008-5472.CAN-09-1618","volume":"69","author":"T Tsuji","year":"2009","unstructured":"Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 2009;69:7135\u20139.","journal-title":"Cancer Res"},{"key":"4005_CR67","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat Med. 2014;20:1301\u20139.","journal-title":"Nat Med"},{"key":"4005_CR68","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Coyington KR, Contreras A, Fuqua SAW, et al. Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer. Clin. Cancer Res. 2015;21:1688\u201398.","journal-title":"Clin. Cancer Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04005-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04005-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T04:11:43Z","timestamp":1669954303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04005-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,27]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["4005"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04005-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.02.279133","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,27]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Data from patients were retrieved from publicly available databases. Informed consent was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"742"}}